These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 17251808)

  • 21. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tear osmolarity as a biomarker for dry eye disease severity.
    Suzuki M; Massingale ML; Ye F; Godbold J; Elfassy T; Vallabhajosyula M; Asbell PA
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4557-61. PubMed ID: 20393114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study.
    Troiano P; Monaco G
    Cornea; 2008 Dec; 27(10):1126-30. PubMed ID: 19034126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
    Kim EC; Choi JS; Joo CK
    Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regression of lid-parallel conjunctival folds (LIPCOF) on topical treatment with Liposic Eye Gel--a pilot study].
    Höh H; Schwanengel M
    Klin Monbl Augenheilkd; 2006 Nov; 223(11):918-23. PubMed ID: 17131254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tear lipocalin and lysozyme concentrations in postmenopausal women.
    Srinivasan S; Joyce E; Boone A; Simpson T; Jones L; Senchyna M
    Ophthalmic Physiol Opt; 2010 May; 30(3):257-66. PubMed ID: 20444132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compliance with and typical usage of artificial tears in dry eye conditions.
    Swanson M
    J Am Optom Assoc; 1998 Oct; 69(10):649-55. PubMed ID: 9805446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.
    Russo PA; Bouchard CS; Galasso JM
    Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management.
    Sullivan BD; Crews LA; Sönmez B; de la Paz MF; Comert E; Charoenrook V; de Araujo AL; Pepose JS; Berg MS; Kosheleff VP; Lemp MA
    Cornea; 2012 Sep; 31(9):1000-8. PubMed ID: 22475641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.
    Su MY; Perry HD; Barsam A; Perry AR; Donnenfeld ED; Wittpenn JR; D'Aversa G
    Cornea; 2011 Oct; 30(10):1098-104. PubMed ID: 21407074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
    Rao SN; Rao RD
    Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of tear hyperosmolarity on conjunctival cells in mild to moderate dry eye.
    Julio G; Lluch S; Pujol P; Merindano MD
    Ophthalmic Physiol Opt; 2012 Jul; 32(4):317-23. PubMed ID: 22620852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal progression and spatial repeatability of tear breakup.
    Liu H; Begley CG; Chalmers R; Wilson G; Srinivas SP; Wilkinson JA
    Optom Vis Sci; 2006 Oct; 83(10):723-30. PubMed ID: 17041317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction.
    Goto E; Shimazaki J; Monden Y; Takano Y; Yagi Y; Shimmura S; Tsubota K
    Ophthalmology; 2002 Nov; 109(11):2030-5. PubMed ID: 12414410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New test to quantify lipid layer behavior in healthy subjects and patients with keratoconjunctivitis sicca.
    Rolando M; Valente C; Barabino S
    Cornea; 2008 Sep; 27(8):866-70. PubMed ID: 18724144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of lubricating eyedrops on ocular light scattering as a measure of vision quality in patients with dry eye.
    Diaz-Valle D; Arriola-Villalobos P; García-Vidal SE; Sánchez-Pulgarín M; Borrego Sanz L; Gegúndez-Fernández JA; Benitez-Del-Castillo JM
    J Cataract Refract Surg; 2012 Jul; 38(7):1192-7. PubMed ID: 22727288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
    Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
    Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Objective optical assessment of tear-film quality dynamics in normal and mildly symptomatic dry eyes.
    Benito A; Pérez GM; Mirabet S; Vilaseca M; Pujol J; Marín JM; Artal P
    J Cataract Refract Surg; 2011 Aug; 37(8):1481-7. PubMed ID: 21782090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy, tolerability and comfort of a 0.3% hypromellose gel ophthalmic lubricant in the treatment of patients with moderate to severe dry eye syndrome.
    Tauber J
    Curr Med Res Opin; 2007 Nov; 23(11):2629-36. PubMed ID: 17868503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.